Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine

scientific article published on 19 January 2014

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIU048
P698PubMed publication ID24446529
P5875ResearchGate publication ID259827073

P50authorMel KrajdenQ6810759
Naveed Zafar JanjuaQ39716263
Salaheddin M. MahmudQ42242293
James A DickinsonQ42422634
Yan LiQ69032212
Nathalie BastienQ69032280
Hugues CharestQ86870110
Gaston De SerresQ86870133
Jonathan B GubbayQ87716515
Danuta M. SkowronskiQ111259505
Suzana SabaiducQ114718265
Martin PetricQ114718266
Anne-Luise WinterQ114718267
Kevin FonsecaQ114718268
Paul Van CaeseeleQ114718272
Trijntje L KwindtQ114718277
P2860cites workCross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominanceQ28728106
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.Q30357784
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from CanadaQ30388012
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.Q30399334
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisQ30408691
Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in childrenQ30409092
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimatesQ33554684
Serologic assays for influenza surveillance, diagnosis and vaccine evaluationQ34194336
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 seasonQ34614814
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisQ34783486
Recent changes among human influenza virusesQ35784247
Variable efficacy of repeated annual influenza vaccinationQ36705674
Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the seasonQ36849805
Influenza vaccine effectiveness in the community and the householdQ36956943
Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?Q37084793
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasonsQ42239081
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolutionQ42253862
Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/YamagataQ42613649
Kinetics of the antibody response to seasonal influenza vaccination among the elderlyQ43171479
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasonsQ43209729
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variantsQ45167252
Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution requiredQ45375388
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year periodQ45760959
Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm.Q45932844
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 seasonQ47843797
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.Q48071872
Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.Q50637887
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.Q50801938
Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy AdultsQ51152487
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohortQ57384993
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectvaccineQ134808
P304page(s)126-137
P577publication date2014-01-19
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleInfluenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine
P478volume210

Reverse relations

cites work (P2860)
Q475839202015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.
Q400870982015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Q39322780A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.
Q38692107A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.
Q38671179A systematic review of the health economic consequences of quadrivalent influenza vaccination.
Q41932798Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada
Q35211657Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany
Q50065275Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness
Q47613621Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada
Q47678684Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons
Q30891396Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis
Q92828089Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach
Q39215322Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera
Q53283393Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
Q30401497Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus
Q30391150Effect of Statin Use on Influenza Vaccine Effectiveness
Q30403059Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain
Q35758531Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results
Q41932605Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
Q34451202Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies
Q40015287Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
Q58722425Estimating Vaccine-Driven Selection in Seasonal Influenza
Q38660898Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
Q37669436Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy.
Q90186606Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018
Q64276594HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
Q54263414Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis.
Q38408953Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
Q59349308Immune History and Influenza Vaccine Effectiveness
Q26744404Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials
Q34393525Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons
Q90108100Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features
Q30383312Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
Q37568360Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses
Q47137946Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada
Q39833076Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment
Q34505958Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain
Q35531934Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type
Q38415770Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season
Q54261205Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.
Q87852509Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
Q42237299Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
Q41474318Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.
Q42148972Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.
Q87601707Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system
Q64126022Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment
Q35130915Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses
Q47413448Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Q92498126Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017
Q36296560Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea
Q39813068Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
Q47229285Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou, China
Q34778408Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
Q36090140Prediction of influenza B vaccine effectiveness from sequence data
Q40374569Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans
Q97530377Quantifying the annual incidence and underestimation of seasonal influenza: A modelling approach
Q40143693Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness.
Q39340731Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
Q49400944Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.
Q57100141Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
Q35225209Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations
Q36847186The Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010-2015: The Experience of Sicily and Liguria
Q90692852The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Q34194443The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013.
Q38639994The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
Q60912426The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
Q37010796Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study
Q47160827Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada
Q38803189Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

Search more.